Procter & Gamble Company (The) $PG Position Lowered by Bryn Mawr Trust Advisors LLC

Bryn Mawr Trust Advisors LLC reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 120,648 shares of the company’s stock after selling 3,349 shares during the quarter. Bryn Mawr Trust Advisors LLC’s holdings in Procter & Gamble were worth $17,528,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new stake in Procter & Gamble in the 2nd quarter worth approximately $27,862,105,000. State Street Corp boosted its stake in shares of Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company’s stock valued at $14,988,999,000 after buying an additional 965,461 shares during the period. Bank of America Corp DE acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at $3,850,628,000. Bank of New York Mellon Corp purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at $2,281,505,000. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock valued at $1,704,182,000 after acquiring an additional 300,280 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Price Performance

Shares of PG opened at $165.31 on Monday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72. The firm has a market cap of $383.15 billion, a PE ratio of 24.90, a PEG ratio of 4.07 and a beta of 0.36. The firm’s 50 day moving average price is $152.01 and its 200 day moving average price is $149.43. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $170.52.

Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The company had revenue of $23.28 billion during the quarter, compared to the consensus estimate of $22.80 billion. During the same period in the previous year, the firm posted $1.99 earnings per share. The company’s revenue for the quarter was up 4.0% compared to the same quarter last year. As a group, research analysts expect that Procter & Gamble Company will post 6.99 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a $1.0885 dividend. This represents a $4.35 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is presently 65.51%.

Analyst Ratings Changes

A number of research firms have recently weighed in on PG. Morgan Stanley upped their price target on shares of Procter & Gamble from $166.00 to $185.00 and gave the stock an “overweight” rating in a research note on Friday, October 23rd. Wells Fargo & Company lifted their price objective on Procter & Gamble from $164.00 to $180.00 and gave the company an “overweight” rating in a research report on Friday, October 23rd. Barclays boosted their target price on Procter & Gamble from $152.00 to $165.00 and gave the company an “equal weight” rating in a research note on Monday, October 26th. Evercore upgraded Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 target price on the stock in a research note on Tuesday, October 6th. Finally, Freedom Broker raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 target price on the stock in a research report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus target price of $170.57.

Check Out Our Latest Research Report on Procter & Gamble

Procter & Gamble News Roundup

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: P&G has raised its dividend for 70 consecutive years. Its quarterly payout is about $1.09 per share, equivalent to a roughly 2.6% yield, supporting the stock’s appeal to income-focused investors. Article: P&G dividend history and yield
  • Positive Sentiment: Recent coverage points to investor interest in consumer-staples stocks as technology shares weaken. P&G may benefit from its defensive profile and dividend reputation. Article: Consumer staples rotation
  • Neutral Sentiment: Zacks Research made mixed earnings-estimate changes: it lowered several forecasts for 2027 and 2028, while modestly raising some later-period estimates. The mixed revisions offer no clear overall change in the longer-term outlook. Procter & Gamble analyst estimates
  • Neutral Sentiment: Management will discuss strategy and P&G’s long-term transformation at an Investor Day webcast on November 19; investors may look for updates on growth and execution. Article: P&G Investor Day webcast
  • Negative Sentiment: CFO Andre Schulten sold 33,624 shares for about $5.55 million, reducing his direct stake by roughly 34%. The sale may concern investors, although insider transactions alone do not establish a change in the company’s prospects. Article: CFO share sale

Insiders Place Their Bets

In related news, CAO Matthew Janzaruk sold 9,479 shares of the company’s stock in a transaction on Tuesday, November 3rd. The shares were sold at an average price of $163.00, for a total value of $1,545,077.00. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at approximately $207,173. This represents a 88.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 33,624 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $165.00, for a total transaction of $5,547,960.00. Following the transaction, the chief financial officer directly owned 65,618 shares in the company, valued at $10,826,970. The trade was a 33.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 161,709 shares of company stock worth $26,244,058 in the last 90 days. 0.23% of the stock is owned by corporate insiders.

Procter & Gamble Company Profile

(Free Report)

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.